ATE234615T1 - Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren - Google Patents

Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren

Info

Publication number
ATE234615T1
ATE234615T1 AT97310391T AT97310391T ATE234615T1 AT E234615 T1 ATE234615 T1 AT E234615T1 AT 97310391 T AT97310391 T AT 97310391T AT 97310391 T AT97310391 T AT 97310391T AT E234615 T1 ATE234615 T1 AT E234615T1
Authority
AT
Austria
Prior art keywords
treatment
acetylcystone
production
ulcers
medicinal product
Prior art date
Application number
AT97310391T
Other languages
English (en)
Inventor
Stephen Bloor
Original Assignee
Johnson & Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd
Application granted granted Critical
Publication of ATE234615T1 publication Critical patent/ATE234615T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97310391T 1996-12-20 1997-12-19 Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren ATE234615T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9626468A GB2320431B (en) 1996-12-20 1996-12-20 Compositions for the treatment of chronic wounds

Publications (1)

Publication Number Publication Date
ATE234615T1 true ATE234615T1 (de) 2003-04-15

Family

ID=10804743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97310391T ATE234615T1 (de) 1996-12-20 1997-12-19 Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren

Country Status (11)

Country Link
US (1) US6166084A (de)
EP (1) EP0848951B1 (de)
JP (1) JPH10273438A (de)
AT (1) ATE234615T1 (de)
AU (1) AU726545B2 (de)
CA (1) CA2225202A1 (de)
CO (1) CO4930267A1 (de)
DE (1) DE69719931T2 (de)
GB (1) GB2320431B (de)
SG (1) SG63786A1 (de)
ZA (1) ZA9711467B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US6685917B2 (en) * 2000-11-22 2004-02-03 Rxkinetix, Inc. Treatment of mucositis
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
DE10121255A1 (de) * 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
EP1425027A4 (de) * 2001-08-16 2008-02-13 Thomas M Hnat Verfahren und zusammensetzung zur behandlung von wunden und verbrennungen
SE522979C2 (sv) * 2002-07-03 2004-03-23 Moelnlycke Health Care Ab Sårförband innefattande en icke-enzymatisk antioxidant
CA2529236A1 (en) * 2004-12-07 2006-06-07 Centre Des Technologies Textiles New antimicrobial material
US8481529B2 (en) * 2006-05-16 2013-07-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona Combination cancer chemotherapy
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
US20090177133A1 (en) * 2008-01-04 2009-07-09 Kristine Kieswetter Reduced pressure dressing coated with biomolecules
WO2010014306A1 (en) * 2008-07-28 2010-02-04 Tyco Healthcare Group Lp Antimicrobial and anticoagulant compositions and methods
GB2470040A (en) * 2009-05-06 2010-11-10 Systagenix Wound Man Ip Co Bv Wound dressing material comprising N-acetyl cysteine
WO2010151778A2 (en) * 2009-06-25 2010-12-29 Darlene Mccord Topical compositions and methods for wound care
US8632512B2 (en) 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US9999702B2 (en) 2010-04-09 2018-06-19 Kci Licensing Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
EP2397125A1 (de) * 2010-06-15 2011-12-21 Histocell, S.L. Antioxidationszusammensetzung
CN105457016B (zh) 2010-09-22 2022-06-24 科罗拉多大学董事会 Smad7的治疗应用
US8597264B2 (en) 2011-03-24 2013-12-03 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
SG11201507045TA (en) * 2013-03-08 2015-10-29 Univ Colorado Regents Ptd-smad7 therapeutics
EP2976095B1 (de) 2013-03-15 2020-12-23 3M Innovative Properties Company Zusammensetzungen zur wundheilung
WO2015127302A1 (en) 2014-02-20 2015-08-27 University Of Notre Dame Du Lac Selective matrix metalloproteinase inhibitors
WO2016044844A1 (en) 2014-09-19 2016-03-24 University Of Notre Dame Du Lac Acceleration of diabetic wound healing
MX2017004520A (es) 2014-10-14 2018-03-15 Lynch Samuel Composiciones para tratar heridas.
MX2019008712A (es) * 2017-01-24 2019-12-09 Recommended By Mom Llc Composiciones basadas en n-acetilcisteina.
US10292998B1 (en) 2018-08-07 2019-05-21 Ahad Mahootchi Compositions and methods for prevention and treatment of eye infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154914A (en) * 1965-08-26 1969-06-11 Mead Johnson & Co Anti-Inflammatory Compositions and methods
ZA702518B (en) * 1969-04-18 1971-01-27 Bristol Myers Co Acetylcysteine for acne
US3749770A (en) * 1969-08-11 1973-07-31 Mead Johnson & Co Compositions containing zinc mercaptide n-acetylcysteine carboxylate salts
US4276284A (en) * 1971-07-26 1981-06-30 Brown Stuart I Prevention of collagenase induced disease by treatment with collagenase inhibitors
FR2519988B1 (fr) * 1982-01-20 1985-06-14 Refarmed Sa Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
IT1194117B (it) * 1981-11-20 1988-09-14 Isnardi Pietro & C Spa Derivati salicilici di n-acetilcisteina
US4414387A (en) * 1982-05-13 1983-11-08 Renato Broggi Cephapirin acetylcysteinate having antibacterial activity
GB8517301D0 (en) * 1985-07-09 1985-08-14 Salim A S M Synergistic biologically active substances
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
IL95393A0 (en) * 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
WO1995000136A1 (en) * 1993-06-18 1995-01-05 Arcturus Pharmaceutical Corporation Method for treating hyperkeratosis and diseases mediated by proteases
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis

Also Published As

Publication number Publication date
ZA9711467B (en) 1999-09-20
GB2320431A8 (en) 1998-12-18
US6166084A (en) 2000-12-26
AU726545B2 (en) 2000-11-09
AU4838397A (en) 1998-06-25
CA2225202A1 (en) 1998-06-20
DE69719931D1 (de) 2003-04-24
CO4930267A1 (es) 2000-06-27
JPH10273438A (ja) 1998-10-13
GB2320431B (en) 2000-08-30
EP0848951A1 (de) 1998-06-24
GB2320431A (en) 1998-06-24
DE69719931T2 (de) 2003-12-24
GB9626468D0 (en) 1997-02-05
EP0848951B1 (de) 2003-03-19
SG63786A1 (en) 1999-03-30

Similar Documents

Publication Publication Date Title
ATE234615T1 (de) Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren
DE69521620T2 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
AU6563596A (en) Treatment of tinnitis using neuroprotective agents
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE69428325T2 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
ATE196738T1 (de) Verwendung von immunglobulin-präparationen zur herstellung eines medikaments zur oralen verabreichung zur behandlung und prophylaxe chronischer schmerzzustände
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATA145488A (de) Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels
ES2093357T3 (es) Metodo de tratamiento de la alopecia.
DE68905657T2 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
ATE232723T1 (de) Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen
ATE192650T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ATE128867T1 (de) Verwendung von 3-aryl-5-alkylthio-4h-1,2,4- triazolen zur behandlung von überreflexen infolge von rückenmarkstrauma.
AU658197B2 (en) New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
ATE307587T1 (de) Verwendung von thiaminen zur herstellung eines arzneimittels zur prophylaxe und zur therapie der diabetischen retinopathie und der diabetischen nephropathie
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
ATE330597T1 (de) Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties